Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,139,096
+$1,831,326 QoQ
Shares Held
28,110
+29.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#1,330
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEANS INVESTMENT CO., INC. holds $25,645,348 across 8 Drug Manufacturers - General names. JNJ ranks #1 (27.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
28,110 | $7,139,096 | |
| 2 | ABBV |
AbbVie Inc.
|
22,908 | $5,764,569 | |
| 3 | LLY |
ELI LILLY & Co
|
4,726 | $5,668,506 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,981 | $3,595,558 | |
| 5 | NVS |
Novartis AG
|
6,330 | $992,037 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,080 | $984,149 | |
| 7 | AMGN |
Amgen Inc
|
2,444 | $885,021 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,879 | $616,412 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,139,096 | 28,110 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,307,770 | 21,714 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $4,530,135 | 21,890 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $4,355,701 | 23,491 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,568,392 | 23,361 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $3,972,863 | 23,956 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $3,824,042 | 26,442 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $4,353,093 | 26,861 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $3,923,811 | 26,846 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $4,542,425 | 28,715 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $4,794,833 | 30,591 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $4,878,245 | 31,321 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $5,394,296 | 32,590 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $5,060,595 | 32,649 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $5,658,982 | 32,035 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $5,138,978 | 31,458 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $5,530,856 | 31,158 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $5,464,355 | 30,832 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $5,091,898 | 29,765 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,849,683 | 30,029 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,003,648 | 30,373 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,814,468 | 29,294 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $4,560,242 | 28,976 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,214,495 | 28,308 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,319,571 | 23,605 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,010,875 | 22,961 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||